Vitiligo: a comprehensive overview Part I. Introduction, epidemiology, quality of life, diagnosis, differential diagnosis, associations, histopathology, etiology, and work-up.

PubWeight™: 1.70‹?› | Rank: Top 3%

🔗 View Article (PMID 21839315)

Published in J Am Acad Dermatol on September 01, 2011

Authors

Ali Alikhan1, Lesley M Felsten, Meaghan Daly, Vesna Petronic-Rosic

Author Affiliations

1: Department of Medical Education, MacNeal Hospital, Berwyn, Illinois, USA.

Associated clinical trials:

Autologous Cell Suspension Grafting Using ReCell in Vitiligo and Piebaldism Patients | NCT02458417

Fractional Laser in Combination With UVB Therapy in Vitiligo Patients | NCT02290717

Bimatoprost 0.03% Solution With NB-UVB Versus Their Use With Fractional Carbon Dioxide Laser in Treatment of Generalized Vitiligo | NCT03487042

Prevalence of Psoriasis and Vitiligo in Assiut Governorate, Egypt | NCT04039451

Effect of Combination Non Steroidal Antiinflammatory Drugs and Narrowband UVB Treatment in Non-Photoadapters | NCT05256147

Articles citing this

CXCL10 is critical for the progression and maintenance of depigmentation in a mouse model of vitiligo. Sci Transl Med (2014) 1.50

Translation, cross-cultural adaptation and validation of the vitiligo-specific health-related quality of life instrument (VitiQoL) into Brazilian Portuguese. An Bras Dermatol (2015) 1.08

Aire deficiency promotes TRP-1-specific immune rejection of melanoma. Cancer Res (2013) 1.06

Simvastatin prevents and reverses depigmentation in a mouse model of vitiligo. J Invest Dermatol (2014) 1.03

Innate immune mechanisms in vitiligo: danger from within. Curr Opin Immunol (2013) 0.97

Concise review of recent studies in vitiligo. Qatar Med J (2013) 0.88

Direct conversion of mouse and human fibroblasts to functional melanocytes by defined factors. Nat Commun (2014) 0.82

Paradoxical reactions under TNF-α blocking agents and other biological agents given for chronic immune-mediated diseases: an analytical and comprehensive overview. RMD Open (2016) 0.81

Significance of the Melanocortin 1 and Endothelin B Receptors in Melanocyte Homeostasis and Prevention of Sun-Induced Genotoxicity. Front Genet (2016) 0.79

Melanocyte-specific CD8+ T cells are associated with epidermal depigmentation in a novel mouse model of vitiligo. Clin Exp Immunol (2013) 0.79

AHR promoter variant modulates its transcription and downstream effectors by allele-specific AHR-SP1 interaction functioning as a genetic marker for vitiligo. Sci Rep (2015) 0.79

Decreased Circulating T Regulatory Cells in Egyptian Patients with Nonsegmental Vitiligo: Correlation with Disease Activity. Dermatol Res Pract (2015) 0.78

Vitiligo--Part 2--classification, histopathology and treatment. An Bras Dermatol (2014) 0.77

Thyroid abnormalities in paediatric patients with vitiligo: retrospective study. Postepy Dermatol Alergol (2016) 0.77

Kaliziri extract upregulates tyrosinase, TRP-1, TRP-2 and MITF expression in murine B16 melanoma cells. BMC Complement Altern Med (2014) 0.77

Mimicking Melanosomes: Polydopamine Nanoparticles as Artificial Microparasols. ACS Cent Sci (2017) 0.76

Successful treatment of extensive vitiligo with monobenzone. J Clin Aesthet Dermatol (2012) 0.75

Retinal nerve fiber layer thickness in vitiligo patients. J Res Med Sci (2013) 0.75

Vitiligo blood transcriptomics provides new insights into disease mechanisms and identifies potential novel therapeutic targets. BMC Genomics (2017) 0.75

Plasma Levels of Interleukin-17, Interleukin-23, and Transforming Growth Factor-β in Sudanese Patients with Vitiligo: A Case-Control Study. Indian J Dermatol (2015) 0.75

Development of autoimmune hair loss disease alopecia areata is associated with cardiac dysfunction in C3H/HeJ mice. PLoS One (2013) 0.75

Diphenylcyclopropenone-induced vitiligo in a patient with alopecia universalis. Case Rep Dermatol (2013) 0.75

Pediatric Patients with Vitiligo in Eastern China: Abnormalities in 145 Cases Based on Thyroid Function Tests and Immunological Findings. Med Sci Monit (2015) 0.75

Obtainment of pellets using the standardized liquid extract of Brosimum gaudichaudii Trécul (Moraceae). Pharmacogn Mag (2015) 0.75

Effect of Purified Mushroom Tyrosinase on Melanin Content and Melanogenic Protein Expression. Biotechnol Res Int (2016) 0.75

Epidermal curettage technique (ECT) for tissue harvest from the donor area for melanocyte autologous grafting in cases of vitiligo. An Bras Dermatol (2014) 0.75

Topical mycophenolate mofetil in the treatment of vitiligo: a pilot study. Dermatol Pract Concept (2017) 0.75

The Prevalence of Vitiligo: A Meta-Analysis. PLoS One (2016) 0.75

Reduced serum brain-derived neurotrophic factor in patients with first onset vitiligo. Neuropsychiatr Dis Treat (2014) 0.75

Enhanced bleaching treatment: opportunities for immune-assisted melanocyte suicide in vitiligo. Exp Dermatol (2014) 0.75

Pattern of Childhood Onset Vitiligo at a Tertiary Care Centre in South- West Rajasthan. Indian J Dermatol (2015) 0.75

Correlation between Serum Homocysteine and Vitiligo Area Scoring Index. Open Access Maced J Med Sci (2017) 0.75

A comparative study of combined treatment with fractional carbon dioxide and targeted ultraviolet B phototherapy for facial vitiligo. Lasers Med Sci (2016) 0.75

Vitiligo: what's new in the psycho-neuro-endocrine-immune connection and related treatments. Wien Med Wochenschr (2014) 0.75

Depigmentation with Q-switched Nd:YAG laser in universal vitiligo: a long-term follow-up study of 4 years. Lasers Med Sci (2017) 0.75

Evaluation of Histologically and Histochemically Proven Cases of Vitiligo and its Correlation with CD4+ and CD8+ Lymphocyte Counts using Flow Cytometry. J Clin Diagn Res (2017) 0.75

Effect of combination of fractional CO2 laser and narrow-band ultraviolet B versus narrow-band ultraviolet B in the treatment of non-segmental vitiligo. Lasers Med Sci (2017) 0.75

Articles by these authors

Vitiligo: a comprehensive overview Part II: treatment options and approach to treatment. J Am Acad Dermatol (2011) 1.82

Early morphea simulating patch-stage mycosis fungoides. Am J Dermatopathol (2015) 1.39

Pyoderma gangrenosum related to a new granulocyte colony-stimulating factor. Skinmed (2006) 1.14

Dermatitis herpetiformis. Part I. Epidemiology, pathogenesis, and clinical presentation. J Am Acad Dermatol (2011) 1.14

Dermatitis herpetiformis. Part II. Diagnosis, management, and prognosis. J Am Acad Dermatol (2011) 0.95

XPC silencing in normal human keratinocytes triggers metabolic alterations that drive the formation of squamous cell carcinomas. J Clin Invest (2010) 0.92

Clinicopathologic challenge. Neutrophilic dermatosis of the dorsal hands--a variant of localized Sweet's syndrome. Int J Dermatol (2009) 0.86

Autoimmune bullous diseases in childhood. Clin Dermatol (2011) 0.85

The treatment of diffuse dermal angiomatosis of the breast with reduction mammaplasty. Arch Dermatol (2008) 0.83

Pityriasis rosea-like drug eruption due to nortriptyline in a patient with vulvodynia. J Low Genit Tract Dis (2013) 0.81

Nevus versus melanoma: to FISH, or not to FISH. Adv Anat Pathol (2011) 0.80

Ossified soft tissue leiomyoma in a patient with sickle cell anemia. J Cutan Pathol (2005) 0.80

Epidermolytic hyperkeratosis within infundibular cysts. J Cutan Pathol (2007) 0.79

Cost-effectiveness of a hydroquinone/tretinoin/fluocinolone acetonide cream combination in treating melasma in the United States. J Dermatolog Treat (2010) 0.78

Update on immunohistochemical methods relevant to dermatopathology. Arch Pathol Lab Med (2009) 0.78

Clinical decision making based on histopathologic grading and margin status of dysplastic nevi. Arch Dermatol (2012) 0.77

Basal Cell Carcinoma. Part 1: Basal Cell Carcinoma Has Come of Age. Skinmed (2015) 0.76

Full-thickness eyelid lesions in sarcoidosis. Case Rep Ophthalmol Med (2013) 0.76

Cutaneous drug eruptions induced by sorafenib: a case series. J Drugs Dermatol (2008) 0.76

Immunohistochemistry for immunoglobulin G4 on paraffin sections for the diagnosis of pemphigus. Arch Pathol Lab Med (2012) 0.75

Sine versus siné: rigorous nomenclature in dermatology. J Am Acad Dermatol (2007) 0.75

Obstacles to skin cancer detection and prevention. Skinmed (2006) 0.75

Erythema multiforme-like presentation of chronic graft versus host disease. J Am Acad Dermatol (2008) 0.75

The Keyes Award and Edward Lawrence Keyes, MD (1843-1924). Skinmed (2013) 0.75

Cold panniculitis following ice therapy for cardiac arrhythmia. Pediatr Dermatol (2011) 0.75

Survey of demographic and educational factors among dermatology chairs and chiefs. Cutis (2012) 0.75

Pityriasis rubra pilaris sensitive to narrow band-ultraviolet B light therapy. J Drugs Dermatol (2009) 0.75

Erlotinib-induced scalp perifolliculitis. Skinmed (2012) 0.75

Amelanocytic anhidrotic alopecia areata-like phenotype after allogeneic hematopoietic cell transplant. Arch Dermatol (2012) 0.75

Folliculocentric lichen sclerosus et atrophicus. Skinmed (2010) 0.75

Therapy-related myeloid sarcoma with an NPM1 mutation. Leuk Lymphoma (2010) 0.75

Subepidermal calcified nodule in a 7-month-old boy. Skinmed (2007) 0.75

Acquired combined nutritional deficiency presenting as psoriasiform dermatitis. J Am Acad Dermatol (2010) 0.75

Advice for fourth year medical students beginning the dermatology residency application process: Perspectives from interns who matched. Dermatol Online J (2009) 0.75

Clinicopathologic challenge. Sclerodermoid graft-versus-host disease (GVHD) with lichensclerosus-like lesions. Int J Dermatol (2008) 0.75

Bullous pemphigoid in late childhood successfully treated with mycophenolate mofetil as an adjuvant therapy. Pediatr Dermatol (2010) 0.75

Erythematous eruption with marked conjunctival injection--quiz case. Diagnosis: leukemia cutis with conjunctival involvement in the setting of T-cell prolymphocytic leukemia (T-PLL). Arch Dermatol (2012) 0.75

Eosinophilic granuloma of the skin: response to intralesional corticosteroid injection. J Drugs Dermatol (2007) 0.75

Clinicopathologic challenge. Regional lymphomatoid papulosis, type A. Int J Dermatol (2007) 0.75

Cutaneous Churg-Strauss syndrome: response to dapsone therapy. J Am Acad Dermatol (2011) 0.75

Reticulated phototoxic eruption in a patient on long-term diltiazem therapy. J Drugs Dermatol (2008) 0.75